The Legal Intelligencer | Commentary
By Judith D. Cassel and Melissa A. Chapaska | June 7, 2018
Because marijuana is still frustratingly and inappropriately listed on Schedule 1 of the Controlled Substance Act (21 U.S.C. Section 321 et seq.)…
The Legal Intelligencer | Commentary
By Jonathan A. Haven and Ruth A. Rauls | May 26, 2018
On April 5, the Pennsylvania Department of Health (PADOH), Office of Medical Marijuana (OMM), which oversees the commonwealth's medical marijuana program, initiated phase II of its licensing process.
The Legal Intelligencer | Commentary
By William F. McDevitt | May 21, 2018
The sale of cannabis is illegal under federal law in all 50 states, U.S. territories and U.S. possessions. Yet, as of May 1, 29 states, the District of Columbia, and Guam and Puerto Rico recognized the legality of marijuana in some form (raw or processed) and for some purpose (medicinal or adult-use/recreational).
By Scott Flaherty | May 9, 2018
LabMD, a medical testing company mired in legal battles, alleges that Mary Beth Buchanan and Bryan Cave Leighton Paisner concealed key information in an FTC consumer protection case.
By Charles S. Marion | May 8, 2018
During the last few years, there has been an explosion in the number of lawsuits being filed claiming that a business' website violates the Americans with Disabilities Act (ADA).
The Legal Intelligencer | News
By Max Mitchell | April 27, 2018
The jury rendered its verdict Friday morning, after more than two weeks of trial and about two days of deliberation.
The Legal Intelligencer | Commentary
By Peter Murphy and Daniel Clearfield | April 25, 2018
On March 22, the Pennsylvania Department of Health (the department) announced it will begin accepting applications for medical marijuana dispensary and grower/processor permits as early as April. During this second round, the department will issue 13 additional permits to grow and process medical marijuana, and 23 dispensary permits. Completed applications must be postmarked no later than May 17.
The Legal Intelligencer | News
By Max Mitchell | April 24, 2018
If Janssen Pharmaceuticals was the Cleveland Cavaliers, then its blockbuster blood thinner medication Xarelto was the company's LeBron James, an attorney suing the drugmaker told a Philadelphia jury during closing arguments in the latest state court trial over the drug's safety.
The Legal Intelligencer | News
By Max Mitchell | April 23, 2018
A federal judge has rejected an insurance provider's attempts to invalidate a $125 million settlement that the company, and several others, entered into with the makers of the sleep-disorder drug Provigil.
By The Legal Intelligencer | April 23, 2018
As part of The Legal's upcoming Professional Excellence supplement, which will publish on June 12, we are pleased to announce the three finalists for Attorney of the Year.
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
We are seeking an associate to join our Employee Benefits practice. Candidates should have three to six years of employee benefits experienc...
Associate attorney position at NJ Immigration Law firm: Leschak & Associates, LLC, based in Freehold, NJ, is looking for a full time ass...
Duane Morris LLP has an immediate opening for a senior level, highly motivated litigation associate to join its dynamic and growing Employme...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS